GRK5 and prostate carcinoma: Additionally, a KD by a pool of GRK5 siRNAs was performed in another breast cancer (HS-578T) and two prostate cancer cell lines (DU-145, PC-3) (Fig. 2E) and its effect on cancer cell migration was confirmed (Fig. 2F).